CBT for Menopause: Improving Sleep and Hot Flashes Without Medication
CBT tailored for menopause may improve insomnia, hot flashes, and mood. New research highlights benefits—and the need for strategies to sustain improvements over time.
CBT tailored for menopause may improve insomnia, hot flashes, and mood. New research highlights benefits—and the need for strategies to sustain improvements over time.
Sleep disturbance is common in peri- and postmenopausal women, even in the absence of VMS, and is independently linked to worse quality of life, depression, and anxiety.
How should psychiatrists think about hormone therapy in perimenopause? This article explains when, why, and how to consider MHT for perimenopausal women with mood and anxiety symptoms.
Current guidelines list gabapentin as a recommended nonhormonal therapy for vasomotor symptoms in women who cannot or prefer not to use hormone therapy.
A New Drug Application was submitted to the FDA for a novel, nonhormonal dual neurokinin-1 and neurokinin-3 receptor antagonist for the treatment of menopause-related vasomotor symptoms.
The FDA accepted a New Drug Application for fezolinetant, a novel, nonhormonal selective neurokinin-3 receptor (NK3R) antagonist for the treatment of menopause-related vasomotor symptoms.
In this episode of It’s Not a Crisis, Dr. Lee Cohen speaks with host Doryn Wallach about the struggles many women experience during the menopausal transition. For most women, menopausal symptoms are manageable, but for [...]
CBT is effective for the management of vasomotor symptoms, depression, and sleep in perimenopausal women.
As women transition into the menopause, they experience a constellation of symptoms including vasomotor symptoms (hot flashes and night sweats), sleep disruption, problems with sexual functioning, and cognitive impairment. Women may also be more [...]
Stimulation of NKB-neurokinin 3 receptor (NK3R) signalling can induce hot flashes